Patent · US Active

Chimeric antigen receptor (CAR) comprising a CD19-binding domain

US11034750B2 · kind B2 · utility

4Cited by
5References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 6, 2018
Grant dateJun 15, 2021
Priority date
Expiry dateSep 16, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a cell which co-expresses a first chimeric antigen receptor (CAR) and second CAR at the cell surface, each CAR comprising an antigen-binding domain, wherein the antigen-binding domain of the first CAR binds to CD19 and the antigen-binding domain of the second CAR binds to CD22.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.